Page last updated: 2024-12-10

12-n-methyl-7-nitrobenzo-2-oxa-1,3-diazolamino stearate

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

You're asking about a very specific chemical compound: **12-n-methyl-7-nitrobenzo-2-oxa-1,3-diazolamino stearate**. This is a mouthful, and there's no widely recognized or documented compound with this exact name.

Here's why:

* **The name doesn't follow standard chemical nomenclature:** It's a bit of a jumble of terms that might be combined differently in proper chemical names.
* **It's likely a hypothetical or theoretical compound:** Without specific research or documentation, it's difficult to determine its actual existence or properties.

**However, let's break down the parts of the name to understand what kind of compound it might be:**

* **12-n-methyl:** This suggests a methyl group (CH3) attached to the 12th carbon of a larger molecule.
* **7-nitrobenzo:** This indicates a nitro group (NO2) attached to a benzene ring (C6H6), likely at the 7th position.
* **2-oxa-1,3-diazolamino:** This describes a heterocyclic ring system with oxygen (oxa) and nitrogen (diaza) atoms, potentially containing an amino group (NH2) attached.
* **Stearate:** This is the anion of stearic acid, a long-chain saturated fatty acid.

**Possible Interpretations and Importance:**

It's highly likely that this compound is a **hypothetical molecule** designed for specific research purposes. Without further context, it's impossible to tell its importance. However, some possibilities include:

* **Drug development:** The compound might be a synthetic molecule designed as a potential drug candidate, incorporating elements of a nitro-aromatic compound, a heterocyclic ring, and a fatty acid chain, all of which are found in various pharmaceuticals.
* **Materials science:** The molecule could be designed for specific material properties, such as self-assembly or light-sensitive behavior.
* **Biochemistry research:** The compound might be a tool for studying biological processes, possibly acting as an inhibitor or a probe for a specific target.

**To understand its true significance, you need more information:**

* **The research context:** What is the specific research area this compound is related to?
* **The source:** Is there a publication, patent, or specific research group associated with this compound?

**If you have more details about the compound or its context, I can help you understand its potential significance more effectively.**

Cross-References

ID SourceID
PubMed CID3081114
MeSH IDM0166870

Synonyms (10)

Synonym
nbd-stearate
octadecanoic acid, 12-(methyl(7-nitro-4-benzofurazanyl)amino)-
12-n-methyl-7-nitrobenzo-2-oxa-1,3-diazolamino stearate
117056-67-4
12-nbds
12-[methyl-(4-nitro-2,1,3-benzoxadiazol-7-yl)amino]octadecanoic acid
bdbm60926
nbd-stearic acid
DTXSID20922270
12-[methyl(7-nitro-2,1,3-benzoxadiazol-4-yl)amino]octadecanoic acid
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (18)

TimeframeStudies, This Drug (%)All Drugs %
pre-19901 (5.56)18.7374
1990's14 (77.78)18.2507
2000's2 (11.11)29.6817
2010's1 (5.56)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.64

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.64 (24.57)
Research Supply Index2.94 (2.92)
Research Growth Index5.58 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.64)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other18 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]